Renustat is a first-in-class, orally administered medication that inhibits HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase). It enhances erythropoiesis (production of red blood cells) by stimulating endogenous erythropoietin production and improving iron regulation. It also helps to overcome the EPO-suppressive effects caused by inflammation, leading to improved hemoglobin synthesis and red blood cell production by downregulating hepcidin levels, a key regulator of iron metabolism.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Indications: Renustat is indicated for the treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients. It is used to improve hemoglobin levels in these patients, especially when anemia becomes symptomatic.
Take Roxadustat orally, with or without food.
Adjust the dose based on hemoglobin levels, following the recommended sequence. Doses should be adjusted to maintain hemoglobin levels between 10 to 12 g/dL. Avoid rapid increases (>2.0 g/dL) in hemoglobin within 4 weeks to minimize risks.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.